CME Group Inc.
As of Fiscal Year 2025 (ended December 31, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total revenue (FY2025) | $6.521 billion, up 6.4% year-over-year |
| Operating income (FY2025) | $4.230 billion, up from $3.932 billion in FY2024 (operating margin of about 65%) |
| Net income attributable to CME Group (FY2025) | $4.021 billion, up 15.5% from $3.482 billion in FY2024 |
| Adjusted net income (FY2025) | $4.036 billion, up from $3.692 billion in FY2024 |
| Diluted EPS (FY2025) | $11.16 GAAP / $11.20 adjusted, versus $9.67 GAAP / $10.26 adjusted in FY2024 |
| Average daily volume (FY2025) | approximately 28.1 million contracts per day, a full-year record |
| Weighted average diluted shares outstanding (FY2025) | about 360.3 million |
| Employees (as of Dec 31, 2025) | 3,875, up about 3% year-over-year |
Sources: Revenue, income, EPS, volume, and headcount figures are from CME Group's 'Reports Fourth Consecutive Year of Record Annual Revenue' Q4/full-year 2025 earnings release (issued February 4, 2026); FY2021-FY2024 total revenue history is from CME's respective full-year earnings releases. Revenue is broken out by CME's disclosed revenue-type categories (clearing and transaction fees; market data and information services; other) because that is how CME's income statement and revenue note disaggregate revenue, rather than by individual asset class (interest rates, equity, energy, agriculture, FX, metals), which CME reports only as trading-volume metrics, not as separate revenue-by-product-line dollar figures. No specific, credibly-sourced third-party numeric market-share estimate for CME's share of U.S. or global exchange-traded derivatives volume was identified in this research (CME is widely described in trade press as the world's largest derivatives marketplace by notional value and open interest, but without an independently-verifiable percentage figure), so no market-share widget is included.